RESIDUAL DISEASE
Clinical trials for RESIDUAL DISEASE explained in plain language.
Never miss a new study
Get alerted when new RESIDUAL DISEASE trials appear
Sign up with your email to follow new studies for RESIDUAL DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising drug combo targets tough breast cancer after surgery
Disease control OngoingThis early-phase study tests the drug niraparib given together with radiation therapy after surgery for triple negative breast cancer. It includes 21 patients who had residual disease after chemotherapy. The goal is to find the safest dose and see if the combination helps prevent…
Matched conditions: RESIDUAL DISEASE
Phase: PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
Can vaccines keep breast cancer away? new study tests two options
Prevention OngoingThis study tests two different vaccines in people who had HER-2 positive breast cancer and still had cancer cells after initial treatment. The goal is to see if the vaccines are safe and can help prevent the cancer from coming back. Participants receive a series of vaccine shots …
Matched conditions: RESIDUAL DISEASE
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Prevention
Last updated May 18, 2026 12:03 UTC